Dr. Mark Goldberg Joins Board to Support Company’s Growth and Expansion
DURHAM, NC – April 3, 2019 – Cato Research, LLC (CATO), a global provider of
regulatory and clinical research services, announced today that its board of directors
has appointed Mark Goldberg, M.D. to executive chairman, effective immediately. Dr.
Goldberg brings to CATO more than 25 years of leadership and innovation experience
in building premier life sciences businesses.
Read Full Press Release
Clinical Trial Operations
Regulatory and Drug Development Consulting
Government and Public Health Services
Biometrics
Clinical Pharmacology Modeling Simulation